ArticlePharmaceutics2026

The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment.

Amelia-Naomi Sabo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.